Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases

Details for Australian Patent Application No. 2004238447 (hide)

Owner Glaxo Group Limited

Inventors Bruton, Gordon; Orlek, Barry Sidney; Rana, Kishore Kalidas

Agent Davies Collison Cave

Pub. Number AU-B-2004238447

PCT Pub. Number WO2004/101546

Priority 0323109.9 02.10.03 GB; 0309222.8 23.04.03 GB

Filing date 21 April 2004

Wipo publication date 25 November 2004

Acceptance publication date 30 October 2008

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 211/62 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/10 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

20 October 2005 PCT application entered the National Phase

  PCT publication WO2004/101546 Priority application(s): WO2004/101546

30 October 2008 Application Accepted

  Published as AU-B-2004238447

19 February 2009 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 22 Jan 2009. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000

11 June 2009 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 22 Jan 2009

19 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004238449-Indazole having analgesic activity ,

2004238410-Amphiphilic trisulfonated porphyrazines for photodynamic applications in medicine